8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Elevance Health, Inc. (ELV)

Elevance Health ($ELV) on Jan 28, 2026 issued a press release reporting Q4 & full‑year 2025 financial…

Filed with the SEC on · Summarized by InvestorsBot

Elevance Health ($ELV) on Jan 28, 2026 issued a press release reporting Q4 & full‑year 2025 financial results; the release is furnished as Exhibit 99.1. 📢 #Earnings #Healthcare

Per the 8‑K, the furnished press release is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into Securities Act filings. 🧾 $ELV #SEC #Filings

Investors: review Exhibit 99.1 for the detailed Q4/FY2025 results furnished Jan 28, 2026 for material metrics and disclosures. 📈 $ELV #Earnings #Investing

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from Elevance Health, Inc.

Elevance Health ($ELV) reaffirms FY2026 adjusted shareholders’ earnings ≥ $25.50/share and 2026 benefit…

8-K · March 10, 2026

Feb 27, 2026: CMS notified Elevance Health ($ELV) of intent to impose intermediate sanctions — suspend…

8-K · March 2, 2026

Elevance Health ($ELV) filed an 8‑K on Feb 26, 2026 furnishing a press release (Exhibit 99.1) and the…

8-K · February 26, 2026

Elevance Health ($ELV) reaffirms FY2026 EPS guidance: ≥ $22.30 diluted (includes ~ $3.20 of net…

8-K · February 26, 2026

Elevance Health ($ELV) announced Feb 26, 2026 that Peter D.

8-K · February 26, 2026

Elevance Health ($ELV) filed an 8‑K on Jan 28, 2026 furnishing a press release (Exhibit 99.1) with…

8-K · January 28, 2026